These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 16455006

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators.
    N Engl J Med; 2005 Jan 06; 352(1):20-8. PubMed ID: 15635109
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reversal of atherosclerosis with aggressive lipid lowering.
    Farmer JA.
    Curr Atheroscler Rep; 2005 Mar 06; 7(2):86-7. PubMed ID: 15727721
    [No Abstract] [Full Text] [Related]

  • 11. [CARDS confirms usefulness of LDL lowering in type 2 diabetics].
    Bern VH.
    Praxis (Bern 1994); 2004 Oct 27; 93(44):1 p following 1830. PubMed ID: 15559908
    [No Abstract] [Full Text] [Related]

  • 12. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug 18; 147(33-34):51. PubMed ID: 16138641
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
    Ridker PM, Morrow DA, Rose LM, Rifai N, Cannon CP, Braunwald E.
    J Am Coll Cardiol; 2005 May 17; 45(10):1644-8. PubMed ID: 15893181
    [Abstract] [Full Text] [Related]

  • 16. Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial.
    Cannon CP, McCabe CH, Belder R, Breen J, Braunwald E.
    Am J Cardiol; 2002 Apr 01; 89(7):860-1. PubMed ID: 11909576
    [No Abstract] [Full Text] [Related]

  • 17. Aggressive lipid-lowering regimen halts CHD progression.
    Geriatrics; 2004 Jan 01; 59(1):44. PubMed ID: 14755869
    [No Abstract] [Full Text] [Related]

  • 18. [Following the ASCOT Study. A statin for every hypertensive patient?].
    MMW Fortschr Med; 2003 Apr 17; 145(16):8. PubMed ID: 14606391
    [No Abstract] [Full Text] [Related]

  • 19. [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].
    Einecke D.
    MMW Fortschr Med; 2006 Jun 15; 148(24):4-5. PubMed ID: 16850796
    [No Abstract] [Full Text] [Related]

  • 20. [High dosage stain protects heart and brain from recurrence].
    MMW Fortschr Med; 2008 Nov 27; 150(48):118-9. PubMed ID: 19125516
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.